Review Article

Neurocognitive Rehabilitation in COVID-19 Patients: A Clinical Review

Authors: Ryan Mathern, MD, Pooja Senthil, BSc, Nguyen Vu, MD, Thanigaiarsu Thiyagarajan, MD

Abstract

COVID-19 has affected many people all around the world for more than two years now have suffered many long-term consequences which is commonly referred to as long-haulers. Despite multiorgan complaints in long haulers, symptoms related to cognitive functions commonly referred as brain fog are seen in the high risk covid patients with age more than 50, women more than men, obesity, asthma and those who experienced more than five symptoms during the first week of covid illness. Long term isolation has certainly contributed to high level of anxiety and stress calling for an empathetic response to this group of covid patients as there is no specific test to detect long haulers and no specific cognitive rehabilitation techniques available as of today.

 
Posted in: Infectious Disease136

Full Article

Having trouble viewing the article content below? Click here to open it directly.

Images

Download Image

Download Image

Download Image

Download Image

References

1. Mahase E. Covid-19: one in three has neurological or psychiatric condition diagnosed after covid infection, study finds. BMJ 2021;373:n908.
 
2. Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416–427.
 
3. How COVID-19 worms its way into the brain – explaining baffling neurological symptoms. https://scitechdaily.com/how-covid-19-worms-its-way-into-the-brain-explaining-baffling-neurological-symptoms/. Published April 27, 2021. Accessed June 6, 2021.
 
4. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77: 683–690.
 
5. Negrini F, Ferrario I, Mazziotti D, et al. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch Phys Med Rehabil 2021;102: 155–158.
 
6. Graham EL, Clark JR, Orban ZS, et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Ann Clin Transl Neurol 2021;8:1073–1085.
 
7. Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue 2020;8:61–69.
 
8. Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARSCoV-2 infection is common and independent of severity of initial infection. PLOS One 2020;15:e0240784.
 
9. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003;160:221–236.
 
10. Norrie J, Heitger M, Leathem J, et al. Mild traumatic brain injury and fatigue: a prospective longitudinal study. Brain Injury 2010;24:1528–1538.
 
11. Marshall M. The lasting misery of coronavirus long-haulers. Nature 2020; 585:339–341. .
 
12. Guan W, Ni Z, Hu Y, et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720.
 
13. Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol 2020;7:2221–2230.
 
14. Bowles L, Platton S, Yartey N, et al. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med 2020;383: 288–290.
 
15. Harzallah I, Debliquis A, Drénou B. (2020). Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost 2020;18:2064–2065.
 
16. Servick K. COVID-19 “brain fog” inspires search for causes and treatments. https://www.sciencemag.org/news/2021/04/covid-19-brain-fog-inspiressearch-causes-and-treatments. Published April 27, 2021. Accessed January 11, 2022.
 
17. Hong I, Velozo CA, Li CY, et al. Assessment of the psychometrics of a PROMIS item bank: self-efficacy for managing daily activities. Qual Life Res 2016;25:2221.
 
18. Tay MRJ, Low YH, Lim CCT, et al. Covert subclinical neurocognitive sequelae during the rehabilitation course of severe coronavirus disease 2019. Am J Phys Med Rehabil 2021;100:39–43.
 
19. Iaccarino MA, Tenforde AS, Zafonte RD, et al. Neurological manifestation of COVID-19 and the enhanced role of physiatrists. Am J Phys Med Rehabil 2020;99:858–859.
 
20. Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020;54:949–959.
 
21. Windsor M. Trial studying technique to clear “brain fog” after COVID-19. https://www.uab.edu/reporter/patient-care/advances/item/9410-trial-studying-technique-to-clear-brain-fog-after-covid-19. Published February 22, 2021. Accessed January 12, 2022.